semaglutide eyes A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Semaglutide May Raise Risk for

Sources Nguyen, T

Ozempic is a prescription medication containing semaglutide, which was initially developed to treat type II diabetes

Semaglutide is a drug that belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists

I wanted to get a head start

A little bit about us: Here at Skin Lab Medical Academy Manuals, we have teamed up with professionals in the beauty industry to create bespoke manuals so you can get on with the important parts of your business

This route however appears to be largely ignored and probably will continue to be ignored, since the strategy so far has been to simply create agonists which are structurally designed to be resistant to DPP-4 (In fact, most modifications to extend the half-life of GLP1R/GIPR/GR agonists so far, do so by making the drugs resistant to DPP-4 )